Menu

Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers

Our Partnership with the European Society for Medical Oncology (ESMO)

About ESMO

ESMO is the leading European professional organisation for medical oncology. The society provides valuable services for every type of oncology professional and has over 13,000 members from over 130 countries, but with a specific focus on Europe.

Our Partnership

The EACR’s partnership with ESMO brings together perspectives from both sides of the lab bench and enables cooperation and exchange of ideas between basic and translational researchers and their clinical colleagues.

“The opportunity is to bring the clinicians and the scientists together in a variety of different fora, in formal meetings and informal discussions, and start asking each other the questions that matter for the cancer patients.”

Richard Marais, EACR Past President 2016-2018

ESMO Congress in Partnership with the EACR

"Integrating science into oncology for a better patient outcome"

In 2017 EACR was an active partner in the ESMO Congress and this partnership will be repeated in 2019. This will give EACR members the opportunity to attend a major congress - in addition to the EACR Biennial Congress - with a reduced registration rate, programme tracks of real interest and relevance, and opportunities to exchange knowledge with the medical oncology community.

We also collaborate on important European research initiatives such as the CAREFOR project, and in oncology events such as the ESMO Symposium on Signalling Pathways.

Click here to visit the ESMO website

Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.